NYSE$PHR
Phreesia Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Announced financial results for the fiscal fourth quarter and fiscal year ended January 31, 2022.
Phreesia's Q4 revenue was $58.0 million, up 39% year-over-year. The average number of healthcare services clients was 2,311, a 28% increase year-over-year, with average revenue per client at $18,430, up 3% year-over-year. Adjusted EBITDA was negative $30.5 million, and cash and cash equivalents totaled $313.8 million.
- Revenue was $58.0 million in the quarter, up 39% year-over-year.
- Average number of healthcare services clients was 2,311 in the quarter, up 28% year-over-year.
- Average revenue per healthcare services client was $18,430, up 3% year-over-year.
- Adjusted EBITDA was negative $30.5 million in the quarter.
Headline financials
Revenue & EPS history
Phreesia · Revenue · Quarterly
$58M
Revenue by segment
Phreesia · $42.6M total across 2 segments · Q4 2022
- Subscription Services$26.4M+40.3%62.1%
- Payment Processing$16.1M+20.0%37.9%
Forward guidance
For the full fiscal year 2023, revenue is expected to be between $271 million and $275 million, implying year-over-year growth of 27% to 29%. Adjusted EBITDA is expected to be between negative $154 million and negative $149 million.
Tailwinds
- Revenue to be between $271 million and $275 million.
- Year-over-year revenue growth of 27% to 29% is expected.
- Expect to see operating leverage in the early part of fiscal year 2024
- Approach profitability in fiscal year 2025
- Introducing an annualized revenue target of $500 million to be achieved during a quarter of fiscal year 2025
Headwinds
- Adjusted EBITDA to be between negative $154 million and negative $149 million.
- Adjusted EBITDA outlook in fiscal 2023 to be the low annual mark for fiscal years 2023 through 2025.
- Uncertainty and potential variability of Other income, net and Provision for (benefit from) income taxes.
- Inability to reasonably predict items.
- Items could have a significant impact on the calculation of GAAP Net income (loss).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2022
-1.6%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+2.0%
Avg return
30 days after
54%
15 / 28 earnings
Positive
+21.4%
Q2 2023
Best reaction
-26.3%
Q4 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -26.3% | -1.1% | — | |
| Q1 2027 | +2.3% | +13.3% | — | |
| Q3 2026 | -22.8% | -19.2% | -16.0% | |
| Q2 2026 | -9.8% | -18.8% | -25.4% | |
| Q1 2026 | -6.6% | -0.2% | +14.2% | |
| Q4 2025 | +6.9% | +14.6% | +1.1% | |
| Q3 2025 | +11.1% | +14.8% | +30.8% | |
| Q2 2025 | +7.9% | +0.5% | -6.8% | |
| Q1 2025 | -13.3% | -14.7% | -2.9% | |
| Q4 2024 | +1.7% | -0.7% | +1.0% | |
| Q3 2024 | +17.8% | +18.8% | +45.2% | |
| Q2 2024 | -21.2% | -27.1% | -39.1% | |
| Q1 2024 | +3.6% | +10.3% | +4.0% | |
| Q4 2023 | -13.5% | -10.0% | -5.7% | |
| Q3 2023 | +18.7% | +34.8% | +20.0% | |
| Q2 2023 | +21.4% | +28.2% | +4.9% | |
| Q1 2023 | +11.9% | +17.5% | +40.1% | |
| Q4 2022 | -11.9% | +1.3% | -23.6% | |
| Q3 2022 | -20.2% | -20.9% | -32.9% | |
| Q2 2022 | -12.4% | -6.2% | -15.4% | |
| Q1 2022 | +6.6% | +12.7% | +24.2% | |
| Q4 2021 | +2.5% | +8.4% | +3.3% | |
| Q3 2021 | +7.3% | +18.1% | +16.2% | |
| Q2 2021 | -3.2% | -9.2% | +3.5% | |
| Q1 2021 | -6.7% | -10.5% | -13.1% | |
| Q4 2020 | +4.2% | +18.1% | +30.6% | |
| Q3 2020 | -1.0% | -8.8% | -6.9% | |
| Q2 2020 | +0.2% | +7.3% | +1.2% | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro